Advanced Lung Disease and Transplant Program, Falls Church, VA; Department of Medicine, Inova Fairfax Hospital, Falls Church, VA.
Fairfax Radiological Consultants, Fairfax, VA; Department of Medicine, Inova Fairfax Hospital, Falls Church, VA.
Chest. 2012 Oct;142(4):1005-1010. doi: 10.1378/chest.12-0298.
The characteristics of long-term survivors with idiopathic pulmonary fibrosis (IPF) have never been fully elucidated. We sought to illustrate the attenuated mortality and describe the characteristics of patients with IPF who survived at least 5 years beyond their initial presentation.
Patients with IPF evaluated between 1997 and 2006 were identified through the clinic database. Patients who survived beyond 5 years from the time of their evaluation were compared with those who died or underwent lung transplantation within 5 years. Survival analyses were performed from the time of initial evaluation and contingent on annualized survival thereafter.
Eighty-seven patients who survived at least 5 years formed the comparator group to whom other patients were contrasted. These patients had a higher BMI, FVC % predicted, FEV1 % predicted, total lung capacity % predicted, and diffusing capacity of lung for carbon monoxide % predicted, but a lower FEV1/FVC ratio and lower mean pulmonary artery pressures. More than one-half of these patients had moderate or severe disease at the time of presentation. Our annualized contingent survival analyses revealed a progressively increasing median survival dependent on the duration of the disease.
Although we were able to demonstrate differences in our 5-year survivors, rather than being a distinct group, these patients appear to exist within a continuum of improving survival dependent on prior disease duration. This progressively improving time-dependent prognosis mandates the serial reevaluation of an individual patient’s projected outcomes. The implementation of dynamic counseling is an important concept in more accurately predicting life expectancy for patients with IPF who are frequently haunted by the prospects of a dismal survival.
特发性肺纤维化(IPF)长期幸存者的特征尚未完全阐明。我们旨在阐明其死亡率降低,并描述至少在初始表现后存活 5 年以上的 IPF 患者的特征。
通过临床数据库确定了 1997 年至 2006 年间评估的 IPF 患者。将存活超过 5 年的患者与在 5 年内死亡或进行肺移植的患者进行比较。从初次评估开始进行生存分析,并取决于此后的年化生存率。
至少存活 5 年的 87 名患者构成了对照组,与其他患者进行了比较。这些患者的 BMI、FVC%预测值、FEV1%预测值、总肺容量%预测值和一氧化碳弥散量%预测值较高,但 FEV1/FVC 比值和平均肺动脉压较低。这些患者中有一半以上在发病时患有中度或重度疾病。我们的年化条件生存分析显示,中位生存时间随着疾病持续时间的延长而逐渐增加。
尽管我们能够证明 5 年幸存者存在差异,但他们并不是一个独特的群体,而是存在于与疾病持续时间相关的生存逐渐改善的连续体中。这种逐渐改善的时间依赖性预后要求对个体患者的预期结果进行定期重新评估。动态咨询的实施是一个重要概念,可以更准确地预测经常受到生存前景黯淡困扰的 IPF 患者的预期寿命。